CLINICAL_TRIALS
trial_result
· 2017-01-13
Clinical Trial Update: A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations [Phase 2]
Summary
Phase 2 trial evaluating PF-03084014 in advanced breast cancer with/without notch alterations; terminated with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Triple Negative Breast Neoplasms | Phase 2 | Status: TERMINATED | Results posted: 2017-01-13